DEB-8

Business and Finance

COVE-8-FIN

Insmed Delivers Its Q2 Scorecard

Insmed posted results and a business update for investors.

^Business^^Earnings^^Biopharma^^Guidance^

Insmed Incorporated Investor Relations

Insmed Reports Second-Quarter 2026 Financial Results and Provides Business Update

—Total Company Revenues of $425.5 Million for the Second Quarter of 2026— —BRINSUPRI® (brensocatib) Revenues of $309.2 Million for the Second Quarter of 2026, Reflecting 49% Growth Over the...